Logo
Menu
  • Who We Are
  • How We Invest
  • Our Portfolio
    • Abzena
    • Ixlayer
    • Kiniciti
    • PathAI
  • Blog
  • Careers
  • Contact
Cell and Gene Therapy 101: A Primer on Advanced Therapies

Cell and Gene Therapy 101: A Primer on Advanced Therapies

by Biospring | Apr 26, 2022 | Biotech, Cell and Gene Therapy, Cell Therapy, CGT, Gene Therapy, Pharma

What if instead of treating the symptoms of a disease, we could target the source of the disease itself? Cell and Gene Therapy (C&GT) can do just that. These advanced therapies are the result of decades of research on the building blocks (cells) and blueprints...
Abzena update with Sven Lee

Abzena update with Sven Lee

by Biospring | Apr 25, 2022 | Abzena, Biologics, Biotech, CDMO, COVID-19, Drug Development, Drug Discovery, Drug Manufacturing, Pharma, Sven Lee

We shared an overview on Abzena following our investment in July. Over the past few months, Abzena has launched a new facility in San Diego and has made several executive hires. We recently spoke with Sven Lee, Chief Business Officer at Abzena, and he provided us with...
Outsourced Manufacturing Key to Future of Drug Development

Outsourced Manufacturing Key to Future of Drug Development

by Biospring | Apr 24, 2022 | Abzena, Biologics, Biotech, CDMO, Drug Development, Pharma

Over the past few months, the COVID-19 pandemic has revealed gaps in the global pharmaceutical supply chain for drugs in clinical trials and for marketed drugs. Drug manufacturing can be a long and complex process requiring specialized expertise. The biopharmaceutical...

Recent Posts

  • Biospring Partners Welcomes Industry Executives To Its Advisory Board
  • Biomanufacturing: A Growing Field
  • Interview with Zach Weinberg
  • Driving Drug Development with Data Science
  • Proteomics 101

Recent Comments

No comments to show.

Newsletter

Thank you for subscribing!

Subscribe